In particular, Lcn2 in microarray and proteomic analysis has been considered as a biomarkers of cancer diagnosis and drug efficacy in the colon of an azoxymethane-induced colon carcinogenesis model and pancreatic cancer of human patients [56,57]. The gene discussed is LCN2; the disease is familial pancreatic carcinoma.